June 8, 2022 PRO Consortium Announces Publication of Open Access Article C-Path’s PRO Consortium is pleased to announce that “Non-Small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ)
April 13, 2022-April 14, 2022 13th Annual Patient-Reported Outcome Consortium Workshop – Held Virtually April 13–14, 2022 On April 13–14, 2022, the 13th Annual Patient-Reported Outcome Consortium Workshop was held in a virtual for
June 7, 2022 C-Path and MitoAction Announce Data Sharing Agreement to Support Treatment Development in Mitochondrial Disease TUCSON, Ariz., June 7, 2022 — Critical Path Institute (C-Path) and MitoAction today announced a joint collaboration to incorpora
xCures joins C-Path’s Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records Members of CDRC will be able to utilize xCures’ technology to quickly abstract and structure clinical data to support drug repur
Biochemist, Biotechnology Expert to Lead C-Path’s Type 1 Diabetes Consortium TUCSON, Ariz., June 2, 2022 — Critical Path Institute (C-Path) has named Elnaz Atabakhsh, Ph.D., as Executive Director of its Ty
C-Path Receives Largest Data Transfer to Date from UK’s National Neonatal Research Database The EPR data transfer is the first from the United Kingdom and includes data from nearly 200 hospitals TUCSON, Ariz., June
June 30, 2022 Sample Size Calculator for a Surrogate Endpoint in Kidney Transplant Clinical Trials When: Thursday, June 30, 10 a.m. – 12 p.m. ET C-Path’s Transplant Therapeutics Consortium (TTC) invites you to jo
FSHD Society and Critical Path Institute Collaborate to Collect Clinical Trial Data TUCSON, Ariz., May 23, 2022 — The FSHD Society, a research-focused patient advocacy nonprofit dedicated to bringing treatments
eCOA Consortium and PRO Consortium Announce Publication of Open Access Article C-Path’s eCOA Consortium and PRO Consortium are pleased to announce that “Recommendations for the Electronic Migration and